Patent · US Active

Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide

US10875867B2 · kind B2 · utility

2Cited by

6References

13Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Christoph Hoenke · Ingelheim am Rhein, DE
Barbara Bertani · Castiglione delle Stiviere, IT
Marco Ferrara · San Donato Milanese, IT
Giacomo Fossati · Lissone, IT
Sara Frattini · Castelleone, IT
Riccardo Giovannini · Verona, IT
Scott Hobson · Mittelbiberach, DE

Key dates

Filing date	Oct 14, 2019
Grant date	Dec 29, 2020
Priority date	—
Expiry date	Oct 14, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide of general formula (I) which are inhibitors of phosphodiesterase 2, useful in treating central nervous system diseases and other diseases.In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.